A Planning Playbook for Opening a New Orthopedic ASC
The ASC market continues its rapid growth. In 2023, roughly 116 new ASCs opened in the U.S., many of which were orthopedic-specific in nature....
This website uses cookies. to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking “Accept & Close”, you consent to our use of cookies. Read our Privacy Policy to learn more.
By: Outpatient Surgery Editors
Published: 3/14/2019
When you rewrite your policy on reducing pressure injuries, you then need to get the right pressure redistributing devices to implement the policy. We invited vendors of positioning products to send us the evidence-based data that supports their products’ efficacy.
Once we trimmed the list of products down to 5, we invited those companies to a 2-day vendor fair, to come on site with a clinical expert and tell us why we should invest in their product to reduce pressure injuries on our patients. This provided a venue for frontline OR staff and physicians to see the products and ask questions. Cost was the last thing we considered. The most important thing to us was the evidence showing the efficacy of the patient positioning devices.
We ended up eliminating foam — foam doesn’t have any pressure redistribution properties — and chose to go with viscoelastic gel pads and positioners.
Amos Schonrock, MAN, RN, CSSM, CNOR, PHN
University of Iowa
Hospitals and Clinics
Iowa City, Iowa
[email protected]
The ASC market continues its rapid growth. In 2023, roughly 116 new ASCs opened in the U.S., many of which were orthopedic-specific in nature....
In her 24 years as a nurse at Penn Medicine, Connie Croce has seen the evolution from open to laparoscopic to robotic surgery....
Through my decades of researching, testing and helping implement healthcare design solutions, I’ve learned an important lesson: A human-centered and evidence-based...